Human immunodeficiency virus antigen

Details Human immunodeficiency virus antigen Human immunodeficiency virus antigen

1987-02-02

1989-08-29

Nucker, Christine M.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

422 61, 435 7, 530350, 530395, 530825, 530826, 436808, 436811, C12Q 170, C07K 1504, C07K 1514, G01N 33569

Patent

active

048617075

ABSTRACT:
A recombinant peptide displaying the antigenicity of Human Immunodeficiency Virus (HIV) viral antigens is disclosed. The peptide comprises an antigenic segment having about 150 to about 400 amino acids corresponding to at least about 30 amino acids of the C-terminal of the gp120 domain and at least about 120 amino acids of the N-terminal of the gp41 domain.

REFERENCES:
patent: 4629783 (1986-12-01), Cosand
patent: 4661445 (1987-04-01), Saxinger et al.
patent: 4692403 (1987-09-01), Linder et al.
patent: 4708818 (1987-11-01), Montagnier et al.
patent: 4716102 (1987-12-01), Levy
patent: 4753873 (1988-06-01), Beltz et al.
Palker et al., "A Conserved Region at the COOH Terminus of Human Immunodeficiency Virus gp120 Envelope Protein Contains an Immunodominant Epitope", Proc. Natl. Acad. Sci., U.S.A., 84, (Apr. 1987), 2479-2483.
Chang et al., "Detection of Antibodies to Human T-Cell Lymphotropic Virus III (HTLV-III) with and Immunoassay Employing a Recombinant Escherichia Coli-Derived Viral Antigenic Peptide", Bio/Technology, 3, (Oct. 1985):905-908.
Pauletti et al., "Application of a Modified Computer Algorithm in Determining Potential Antigenic Determinants Associated with the AIDS Virus Glycoprotein", Analytical Biochemistry, 151, (Dec. 1985): 540-546.
Montagnier et al., "Identification and Antigenicity of the Major Envelope Glycoprotein of Lymphadenopathy-Associated Virus", Virology, 144, (1985):283-289.
Barin et al., "Virus Envelope Protein of HTLV-III Represents Major Target Antigen for Antibodies in AIDS Patients", Science, 228, (May 31, 1985):1094-1096.
Robey et al., "Characterization of Envelope and Core Structural Gene Products of HTLV-III with Sera from AIDS Patients", Science, 228, (May 3, 1985):593-595.
Veronese et al., "Characterization of gp41 As the Transmembrane Protein Coded by the HTLV-III/LAV Envelope Gene", Science, 229, (Sep. 27, 1985):1402-1405.
L. Ratner, et al., Nature, vol. 313, No. 6000, pp. 277-284, 1/24/85, "Complete Nucleotide Sequence of the AIDS Virus, HTLV-III."
S. D. Putney et al., Science, vol. 234, pp. 1392-1395, 12/86, "HTLV-III/LAV-Neutralizing Antibodies to an E. coli-Produced Fragment of the Virus Envelope."
B. R. Starcich et al., Cell, vol. 45, pp. 637-648, 6/86, "Identification and Characterization of Conserved and Variable Regions in the Envelope Gene of HTLV-III/LAV, the Retrovirus of AIDS."
N. W. Tietz et al., Fundamentals of Clinical Chemistry, p. 101.
S. Modrow et al., J. of Virology, vol. 61, No. 2, pp. 570-578, 2/87, "Computer-Assisted Analysis of Envelope Protein Sequences of Seven Human Immunodeficiency Virus Isolates: Predication of Antigenic Epitopes in Conserved and Variable Regions".
R. Crowl et al., Cell, vol. 41, pp. 979-986, 7/85, "HTLV-III env in E. coli are Recognized by Antibodies Present in the Sera of AIDS Patients".
P. N. Lelie et al., IV Int'l AIDS Symposium, Stockholm, 1988, Earlier Detection of HIV-Infection Using Second-Generation Anti-HIV Assays, Poster, 1069.
F. Spielberg et al., Comparative Evaluation of Rapid, Visually Read HIV Antibody Screen Assays at Mama Yemo Hospital, Kinshasa, Zaire, 10/28/88.
D. Stipp, The Wall Street Journal, 6/21/88, p. 14, "Cambridge BioScience Blocked Group from Publishing Data on AIDS Test".
R. Tritch et al., 1986 UCLA Symposia, "Expression of HTLVIII GAG and Envelope Proteins in E. coli: Reaction with AIDS Sera."
D. Reed et al., 1986 UCLA Symposia, "Immunological Characterization of HTLVIII Recombinant Proteins Potential as Diagnostics or Vaccines."
S. R. Petteway, Jr. et al., Viruses and Human Cancer, pp. 15-28, 1987, "Immunological Characterization of the HTLV-III Recombinant Proteins: Potential as Diagnostics and Vaccine Candidates."

Affiliated with

Also associated with

Rating

Human immunodeficiency virus antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human immunodeficiency virus antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human immunodeficiency virus antigen will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2237910